Top ETFs in Singapore in 2021

Across 40 ETF listings, some emerging market offerings delivered stellar results.

Kate Lin 23.12.2021
Facebook Twitter LinkedIn


Here’s how exchange traded funds (ETFs), which are usually passive products that track an index, ended 2021 in Singapore. Top performer, Xtrackers FTSE Vietnam Swap ETF 1C (XVTD) brought investors a 30% return.  iShares MSCI India Index (I98) and Lyxor MSCI India ETF Acc USD (LYINR) ended the period with around 16% gains. Nikko AM Singapore STI ETF (G3B) ranked the tenth, being up 8%.

In the developed world, the U.S. markets continued its robust performance from 2020 and hit new record highs several times this year. Four strategies tracking different US indexes made to the list. Tech-only product, iShares US Technology ETF (IYW) ranked the second, with a 29.6% return. It was followed by an S&P 500 Index strategy, provided by SPDR and Xtrackers. SPDR’s Bronze-rated Dow Jones Industrial ETF posted a positive return of 17.9%.

Bottom Performers

The weakest ETFs this year was Lion-OCBC Securities Hang Seng TECH ETF (HSS), tracking the Hang Seng Tech Index, which slid 30% year-to-date. The index, launched in July 2020, tracks the 30 largest technology companies in Hong Kong. As of November 2021, the top holdings include (09618), Sunny Optical (02382), Meituan (03690), and Tencent (00700).

The second and third worst performers replicate different China equity indexes. Lyxor MSCI Chn ESG Ldrs Extr DR ETF USD (P58) tracks the MSCI China Select ESG Rating and Trend Leaders Index and Xtrackers MSCI China ETF 1C (LG9) tracks the MSCI China Index, each dipping 25% year-to-date.

Three fixed income ETFs were also on the list. iShares Barclays Cap USD Asia HY Bd ETF, ABF Singapore Bond Index, and Xtrackers II Singapore Govt Bd ETF 1C. The former invests in Asian high yield bonds while the latter two are benchmarked to bonds denominated in Singaporean dollar. 


©2021 Morningstar. All rights reserved. The information, data, analyses and opinions presented herein do not constitute investment advice; are provided as of the date written, solely for informational purposes; and subject to change at any time without notice. This content is not an offer to buy or sell any particular security and is not warranted to be correct, complete or accurate. Past performance is not a guarantee of future results. The Morningstar name and logo are registered marks of Morningstar, Inc. This article includes proprietary materials of Morningstar; reproduction, transcription or other use, by any means, in whole or in part, without prior, written consent of Morningstar is prohibited. This article is intended for general circulation, and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Investors should consult a financial adviser regarding the suitability of any investment product, taking into account their specific investment objectives, financial situation or particular needs, before making any investment decisions. Morningstar Investment Management Asia Limited is licensed and regulated by the Hong Kong Securities and Futures Commission to provide investment research and investment advisory services to professional investors only. Morningstar Investment Adviser Singapore Pte. Limited is licensed by the Monetary Authority of Singapore to provide financial advisory services in Singapore. Either Morningstar Investment Management Asia Limited or Morningstar Investment Adviser Singapore Pte. Limited will be the entity responsible for the creation and distribution of the research services described in this article.


Facebook Twitter LinkedIn

About Author

Kate Lin

Kate Lin  is a Data Journalist for Morningstar Asia, and is based in Hong Kong

© Copyright 2024 Morningstar Asia Ltd. All rights reserved.

Terms of Use        Privacy Policy        Disclosures